Chlorcyclizine shows promise in reducing protoporphyrin-IX accumulation and liver damage in erythropoietic protoporphyria, ...

T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for ...

Two abstracts presented at the 2024 American Society of Hematology Annual Meeting & Exhibition provided insight into MDS ...

Hepatic Markers Market. In 2023, the global hepatic markers market is expected to be worth USD 2.3 billion. The market is ...